Open AccessDrug discovery of PD-L1 inhibitor Atezolizumab
Author(s) -
Xinhong Guo,
Xinyi Sheng
Publication year - 2022
Publication title -
highlights in science, engineering and technology
Language(s) - English
Resource type - Journals
ISSN - 2791-0210
DOI - 10.54097/hset.v8i.1253
Subject(s) - atezolizumab , medicine , drug , immunotherapy , intensive care medicine , disease , refractory (planetary science) , oncology , pembrolizumab , cancer , pharmacology , physics , astrobiology